Literature DB >> 21978697

Detection of respiratory viruses in the 2009 winter season in Rome: 2009 influenza A (H1N1) complications in children and concomitant type 1 diabetes onset.

R Nenna1, P Papoff, C Moretti, A Pierangeli, G Sabatino, F Costantino, F Soscia, G Cangiano, V Ferro, M Mennini, S Salvadei, C Scagnolari, G Antonelli, Fabio Midulla.   

Abstract

We investigated clinical characteristics and complications, particularly type 1 diabetes onset, in children hospitalized for 2009 pandemic influenza A (H1N1) virus and compared number of consultations, rate of hospitalization and virus identification in children hospitalized for acute respiratory symptoms (ARS) during the winter season 2009-2010 and 2004-2005. Patients were tested for 2009 H1N1 virus and 14 respiratory viruses on pharyngeal brush/nasal aspirates, using a RT-PCR or nested PCR assays. Consultations and hospitalizations were extracted from operative system GIPSE. The total number of consultations increased by 12%, consultation rate for ARS by 13% and number of hospitalizations by 56% from 2004-2005 to 2009-2010. In 2004-2005, Influenza A virus was identified in only 7 percent of hospitalized children, while in 2009-2010 the 2009 H1N1 virus was identified in 21%. Three children attending the hospital for ARS and 2009 H1N1 infection had ketoacidosis as the onset manifestation of type 1 diabetes. By comparing the number of new diabetes diagnoses among the two winter seasons, we found a higher number of new diagnoses in October 2009-January 2010 than in the same period in 2004-2005 (19 vs 10). Six children (13%), all presenting with pre-existing diseases, were admitted to the pediatric intensive care unit. No children died. The outbreak of this novel virus has increased pediatric consultation rates and hospitalizations compared with previous winters without causing deaths. The children at highest risk for severe infection are those with comorbidities. The 2009 H1N1 virus seems in some way involved in the pathogenesis of type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21978697     DOI: 10.1177/039463201102400311

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  11 in total

Review 1.  Lessons from the mouse: potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes.

Authors:  Jessica A Pane; Barbara S Coulson
Journal:  Diabetologia       Date:  2015-03-21       Impact factor: 10.122

2.  Influenza A viruses grow in human pancreatic cells and cause pancreatitis and diabetes in an animal model.

Authors:  Ilaria Capua; Alessia Mercalli; Matteo S Pizzuto; Aurora Romero-Tejeda; Samantha Kasloff; Cristian De Battisti; Francesco Bonfante; Livia V Patrono; Elisa Vicenzi; Valentina Zappulli; Vito Lampasona; Annalisa Stefani; Claudio Doglioni; Calogero Terregino; Giovanni Cattoli; Lorenzo Piemonti
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

3.  Drug-induced angioedema: experience of Italian emergency departments.

Authors:  G Bertazzoni; M T Spina; M G Scarpellini; F Buccelletti; M De Simone; M Gregori; V Valeriano; F R Pugliese; M P Ruggieri; M Magnanti; B Susi; L Minetola; L Zulli; F D'Ambrogio
Journal:  Intern Emerg Med       Date:  2013-11-09       Impact factor: 3.397

4.  Influenza A virus antibodies show no association with pancreatic islet autoantibodies in children genetically predisposed to type 1 diabetes.

Authors:  Anita Kondrashova; Noora Nurminen; Maarit Patrikainen; Heini Huhtala; Jussi Lehtonen; Jorma Toppari; Jorma Ilonen; Olli G Simell; Riitta Veijola; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2015-08-08       Impact factor: 10.122

5.  Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients.

Authors:  Marsha Pellegrino; Antonino Crinò; Manuela M Rosado; Alessandra Fierabracci
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

Review 6.  Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms.

Authors:  Maria K Smatti; Farhan S Cyprian; Gheyath K Nasrallah; Asmaa A Al Thani; Ruba O Almishal; Hadi M Yassine
Journal:  Viruses       Date:  2019-08-19       Impact factor: 5.048

7.  Hospitalizations from pandemic Influenza [A(H1N1)pdm09] infections among type 1 and 2 diabetes patients in Spain.

Authors:  Rodrigo Jiménez-García; Valentín Hernández-Barrera; Cristina Rodríguez-Rieiro; Ana Lopez de Andres; Javier de Miguel-Diez; Isabel Jimenez-Trujillo; Angel Gil de Miguel; Pilar Carrasco-Garrido
Journal:  Influenza Other Respir Viruses       Date:  2012-08-07       Impact factor: 4.380

8.  Pandemic influenza and subsequent risk of type 1 diabetes: a nationwide cohort study.

Authors:  Paz L D Ruiz; German Tapia; Inger J Bakken; Siri E Håberg; Olav Hungnes; Hanne L Gulseth; Lars C Stene
Journal:  Diabetologia       Date:  2018-06-22       Impact factor: 10.122

9.  Association between influenza and the incidence rate of new-onset type 1 diabetes in Japan.

Authors:  Yuichi Nishioka; Tatsuya Noda; Sadanori Okada; Tomoya Myojin; Shinichiro Kubo; Tsuneyuki Higashino; Hiroki Nakajima; Takehiro Sugiyama; Hitoshi Ishii; Tomoaki Imamura
Journal:  J Diabetes Investig       Date:  2021-04-03       Impact factor: 4.232

10.  Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children.

Authors:  Helena Elding Larsson; Kristian F Lynch; Maria Lönnrot; Michael J Haller; Åke Lernmark; William A Hagopian; Jin-Xiong She; Olli Simell; Jorma Toppari; Anette-G Ziegler; Beena Akolkar; Jeffrey P Krischer; Marian J Rewers; Heikki Hyöty
Journal:  Diabetologia       Date:  2017-10-09       Impact factor: 10.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.